Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rudnick

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Brain Research|August 1, 2009
Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactionsRichard S Ehrlichman, Steven N Luminais, Samantha L White, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 15, 2020
A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant gliomaJeremy D Rudnick, J Manuel Sarmiento, Benjamin Uy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent GlioblastomaJethro L Hu, Oluwaseun A Omofoye, Jeremy D Rudnick, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2012
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaSurasak Phuphanich, Christopher J Wheeler, Jeremy D Rudnick, et al.
Journal of Neurosurgery|September 17, 2022
ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiationGeorge K Hanna, Mecca Madany, Angelique Sao-Mai Sy Tay, et al.
Journal of Neurosurgery|March 5, 2013
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical articleMarlon G Saria, Courtney Corle, Jethro Hu, et al.
Cancer Research|January 20, 2019
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talkTao Sun, Rameshwar Patil, Anna Galstyan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled TrialByram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Brain Research|August 1, 2009
Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactionsRichard S Ehrlichman, Steven N Luminais, Samantha L White, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 15, 2020
A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant gliomaJeremy D Rudnick, J Manuel Sarmiento, Benjamin Uy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent GlioblastomaJethro L Hu, Oluwaseun A Omofoye, Jeremy D Rudnick, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 2012
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaSurasak Phuphanich, Christopher J Wheeler, Jeremy D Rudnick, et al.
Journal of Neurosurgery|September 17, 2022
ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiationGeorge K Hanna, Mecca Madany, Angelique Sao-Mai Sy Tay, et al.
Journal of Neurosurgery|March 5, 2013
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical articleMarlon G Saria, Courtney Corle, Jethro Hu, et al.
Cancer Research|January 20, 2019
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talkTao Sun, Rameshwar Patil, Anna Galstyan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled TrialByram H Ozer, Scott M Lindhorst, Ryan T Merrell, et al.
Pageof 5